{
    "SLCO1A2": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": "0.0825"
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": "0.00199"
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": "0.00324"
            },
            {
                "Organ": "Placenta",
                "Source": "Nishimura",
                "Relative Expression": "0.000130"
            },
            {
                "Organ": "Small Intestine*",
                "Source": "Nishimura",
                "Relative Expression": "0.0000198"
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "0.610"
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Bromsulphthalein (BSP)",
                "IC50 (μM)": "3.75",
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "COS1-OATP1A2",
                "Reference": "Lan, 2009"
            },
            {
                "Inhibitor": "Hesperidin",
                "IC50 (μM)": "2.7",
                "Ki (μM)": null,
                "Substrate used": "Fexofenadine",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Bailey, 2007"
            },
            {
                "Inhibitor": "Naringin",
                "IC50 (μM)": "3.6",
                "Ki (μM)": null,
                "Substrate used": "Fexofenadine",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Bailey, 2007"
            },
            {
                "Inhibitor": "Naringin",
                "IC50 (μM)": "343",
                "Ki (μM)": null,
                "Substrate used": null,
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Shirasaka, 2010"
            },
            {
                "Inhibitor": "Rifampicin*",
                "IC50 (μM)": null,
                "Ki (μM)": 51.0,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Inhibitor": "Rifamycin SV",
                "IC50 (μM)": null,
                "Ki (μM)": 11.0,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Inhibitor": "Ritonavir",
                "IC50 (μM)": "<10",
                "Ki (μM)": null,
                "Substrate used": "Fexofenadine",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Cvetkovic, 1999"
            },
            {
                "Inhibitor": "Saquinavir",
                "IC50 (μM)": "<10",
                "Ki (μM)": null,
                "Substrate used": "Fexofenadine",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Cvetkovic, 1999"
            },
            {
                "Inhibitor": "Verapamil",
                "IC50 (μM)": "2.6",
                "Ki (μM)": null,
                "Substrate used": "Fexofenadine",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Bailey, 2007"
            }
        ],
        "substrates": [
            {
                "Substrate": "Bromsulphthalein (BSP)",
                "Km (μM)": "ND",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Dehydroepiandrosterone sulfate",
                "Km (μM)": "ND",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "13.6",
                "Cell System": "HEK293-OATP1A2",
                "Reference": "Badagnani, 2006"
            },
            {
                "Substrate": "Fexofenadine*",
                "Km (μM)": "6.4",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Cvetkovic, 1999"
            },
            {
                "Substrate": "Levofloxacin",
                "Km (μM)": "136",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Maeda, 2007"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "457",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Badagnani, 2006"
            },
            {
                "Substrate": "Ouabain",
                "Km (μM)": "5.5",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Bossuyt, 1996"
            },
            {
                "Substrate": "Pitavastatin*",
                "Km (μM)": "3.4",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Fujino, 2005"
            },
            {
                "Substrate": "Rosuvastatin*",
                "Km (μM)": "2.6",
                "Cell System": "HeLa-OATP1A2",
                "Reference": "Ho, 2006"
            },
            {
                "Substrate": "Saquinavir",
                "Km (μM)": "36.4",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Su, 2004"
            },
            {
                "Substrate": "Taurocholate",
                "Km (μM)": "60",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Kullak-Ublick, 1995"
            },
            {
                "Substrate": "Tauroursodeoxycholate",
                "Km (μM)": "19",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Kullak-Ublick, 1995"
            },
            {
                "Substrate": "Thyroxine",
                "Km (μM)": "ND",
                "Cell System": "OATP1A2-expressing oocytes",
                "Reference": "Fujiwara, 2001"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Atazanavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "3.1",
                "Cmax": "7.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Busti, 2008",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Docetaxel",
                "AUC": "7.3",
                "Cmax": "5.7",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Malingre, 2001",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Paclitaxel",
                "AUC": "8.5",
                "Cmax": "2.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Meerum, 1999",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Pitavastatin",
                "AUC": "4.6",
                "Cmax": "6.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Livalo Drug Label",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "5.0",
                "Cmax": "10.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "6.4",
                "Cmax": "18.2",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Erythromycin",
                "Affected Drug": "Simvastatin",
                "AUC": "6.2",
                "Cmax": "3.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Indinavir  / Ritonavir",
                "Affected Drug": "Fexofenadine",
                "AUC": "4.8",
                "Cmax": "2.5",
                "CLR": "ND",
                "CL/F": "0.2",
                "t1/2": "0.7",
                "Effect on PD": "ND",
                "Reference": "Kharasch, 2009",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Lopinavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "2.1",
                "Cmax": "4.7",
                "CLR": "ND",
                "CL/F": "0.5",
                "t1/2": "NS",
                "Effect on PD": "yes",
                "Reference": "Kiser, 2008",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Rifampicin",
                "Affected Drug": "Glyburide",
                "AUC": "2.2",
                "Cmax": "1.8",
                "CLR": "NS",
                "CL/F": "0.5",
                "t1/2": "ND",
                "Effect on PD": "yes",
                "Reference": "Zheng, 2009",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Digoxin",
                "AUC": "1.9",
                "Cmax": "ND",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "2.6",
                "Effect on PD": "ND",
                "Reference": "Ding, 2004",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Saquinavir",
                "AUC": "29.9",
                "Cmax": "22.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "la, 2007",
                "More Details": "DDI 12"
            },
            {
                "DDI": "13",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Verapamil",
                "Affected Drug": "Simvastatin",
                "AUC": "4.6",
                "Cmax": "2.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 13"
            }
        ]
    }
}